Kansas City, Mo., September 23, 2026. Joseph L. Hayhurst, MD, founder and CEO of Hayhurst Medical Technologies, presented at 1 Million Cups Kansas City, the weekly Wednesday gathering where local founders share their companies with the community.
Joseph talked about his journey as a founder and about HMT’s work: using new technology to find cancer patients who need specialist care and help them reach it. Thank you to the 1 Million Cups team and everyone who came out and asked questions. (We’ll forgive them for spelling it “Heyhurst.”)
See the post from 1 Million Cups Kansas City.
About Hayhurst Medical Technologies
Hayhurst Medical Technologies (HMT) is a cancer data company building the prospective cancer intelligence network. HMT finds the cancer patients the system misses and gets them to the right care, and in doing so builds the prospective, outcome-linked cancer registry that does not exist yet. Its software reads the reports every cancer patient already generates, structures the findings, and suggests the next step and qualified specialists nearby, with the clinician deciding. HIPEC and peritoneal disease are where HMT starts. Founded by physicians in Kansas City, Missouri, in 2026, HMT is a Delaware corporation.